External beam radiation therapy for thyroid cancer

被引：42
作者：
Brierley, James D. [1 ]
Tsang, Richard W. [1 ]
机构：
[1] Univ Toronto, Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON M5G 2M9, Canada
来源：
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2008年 / 37卷 / 02期
关键词：
D O I：
10.1016/j.ecl.2008.02.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This article discusses the role of external beam radiotherapy (XRT) in the management of well-differentiated thyroid cancer (WDTC), medullary thyroid cancer, and anaplastic thyroid cancer. Although there are no randomized controlled studies on the use of XRT in thyroid cancer, evidence supports its use to treat gross disease after surgery or unresectable cancer and its use as an adjuvant after resection of a known high-risk disease in WDTC, and, to a lesser extent, in medullary thyroid cancer. The use of XRT for the palliation of symptomatic disease and recent advances in the technology of radiation delivery also will be discussed.
引用
收藏
页码：497 / +
页数：14
相关论文
共 62 条
[1]   Prognostic factors in well-differentiated follicular-derived carcinoma and medullary thyroid carcinoma [J].
Baloch, ZW ;
LiVolsi, VA .
THYROID, 2001, 11 (07) :637-645
[2]   Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years [J].
Brierley, J ;
Tsang, R ;
Panzarella, T ;
Bana, N .
CLINICAL ENDOCRINOLOGY, 2005, 63 (04) :418-427
[3]   Medullary thyroid cancer: Analyses of survival and prognostic factors and the role of radiation therapy in local control [J].
Brierley, J ;
Tsang, R ;
Simpson, WJ ;
Gospodarowicz, M ;
Sutcliffe, S ;
Panzarella, T .
THYROID, 1996, 6 (04) :305-310
[4]  
Brierley JD, 2006, PROGNOSTIC FACTORS C, P119
[5]   Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy:: A collaborative study with the French Endocrine Tumor Group [J].
Chatal, JF ;
Campion, L ;
Kraeber-Bodéré, F ;
Bardet, S ;
Vuillez, JP ;
Charbonnel, B ;
Rohmer, V ;
Chang, CH ;
Sharkey, RM ;
Goldenberg, DM ;
Barbet, J .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (11) :1705-1711
[6]   Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition [J].
Chow, Sin-Ming ;
Yau, Stephen ;
Kwan, Chung-Kong ;
Poon, Patricia C. M. ;
Law, Stephen C. K. .
ENDOCRINE-RELATED CANCER, 2006, 13 (04) :1159-1172
[7]   Papillary thyroid carcinoma: Prognostic factors and the role of radioiodine and external radiotherapy [J].
Chow, SM ;
Law, SCK ;
Mendenhall, WM ;
Au, SK ;
Chan, PTM ;
Leung, TW ;
Tong, CC ;
Wong, ISM ;
Lau, WH .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (03) :784-795
[8]   FDG-PET in thyroid cancer [J].
Crippa, F ;
Alessi, A ;
Gerali, A ;
Bombardieri, E .
TUMORI JOURNAL, 2003, 89 (05) :540-543
[9]  
Dottorini ME, 1996, CANCER, V77, P1556, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1556::AID-CNCR20>3.0.CO
[10]  
2-Y
1234567